Evidence map›Paper›PMID 28566371›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4

Karen Cerosaletti, Fariba Barahmand-Pour-Whitman, Junbao Yang, Hannah A DeBerg, Matthew J Dufort, Sara A Murray, Elisabeth Israelsson, Cate Speake, Vivian H Gersuk, James A Eddy and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Breakdown and Repair of Peripheral Immune Tolerance in Type 1 Diabetes.Cold Spring Harbor perspectives in medicine · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. The immunology of type 1 diabetes.Nature reviews. Immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Karen CerosalettiTranslational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101; plinsley@benaroyaresearch.org kcerosaletti@benaroyaresearch.org.
Fariba Barahmand-Pour-WhitmanSystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Junbao YangTranslational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Hannah A DeBergSystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0002-5263-158X
Matthew J DufortSystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0002-5200-0040
Sara A MurraySystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Elisabeth IsraelssonSystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Cate SpeakeDiabetes Clinical Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0003-1480-4272
Vivian H GersukSystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
James A EddySystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0001-9758-0176
Helena ReijonenDiabetes Clinical Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Carla J GreenbaumDiabetes Clinical Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.ORCID 0000-0003-4451-9800
William W KwokTranslational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Erik WambreTranslational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101.
Martin PrlicVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and.ORCID 0000-0002-0685-9321
Raphael GottardoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; and.
Gerald T NepomImmune Tolerance Network, Bethesda, MD 20814.ORCID 0000-0002-8063-1464
Peter S LinsleySystems Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA 98101; plinsley@benaroyaresearch.org kcerosaletti@benaroyaresearch.org.
Virginia Mason Medical Center · USFred Hutch Cancer Center · USImmune Tolerance Network · US

Funding

Immune Tolerance Network UM1 2023 SupplementUM1AI109565 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI Mark S Anderson, Jane Hoyt Buckner · 2014 to 2026
$451.6M
Paving the Way for a Novel Therapeutic Approach to Combat HIVDP2DE023321 · NIDCR · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRLIC, MARTIN · 2012 to 2014
$2.9M
Phenotypic Analysis of Islet Antigen-specific Effector T Cells in Pre-diabetic SubjectsDP3DK106909 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI KWOK, WILLIAM W. · 2015 to 2015
$2.2M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
Single Cell Transcriptome Analysis of Islet Antigen Reactive Memory CD4+ T Cells in Establshed T1DDP3DK110867 · NIDDK · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI LINSLEY, PETER S · 2016 to 2016
$510k
NIAID NIH HHS HHSN272201300006CNIAID NIH HHS UM1 AI109565NIDCR NIH HHS DP2 DE023321NIDDK NIH HHS DP3 DK106909NIDDK NIH HHS DP3 DK110867NIH HHS S10 OD020069
6 · The paper itself

Abstract

The significance of islet Ag-reactive T cells found in peripheral blood of type 1 diabetes (T1D) subjects is unclear, partly because similar cells are also found in healthy control (HC) subjects. We hypothesized that key disease-associated cells would show evidence of prior Ag exposure, inferred from expanded TCR clonotypes, and essential phenotypic properties in their transcriptomes. To test this, we developed single-cell RNA sequencing procedures for identifying TCR clonotypes and transcript phenotypes in individual T cells. We applied these procedures to analysis of islet Ag-reactive CD4

Indexed as

Lymphocyte ActivationAdultCD4-Positive T-LymphocytesClone CellsDiabetes Mellitus, Type 1FemaleGene Expression ProfilingHumansImmunologic MemoryIslets of LangerhansMalePeptidesPhenotypeReceptors, Antigen, T-Cell, alpha-betaSequence Analysis, RNASingle-Cell AnalysisPeptidesReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID28566371
PMCPMC5499675
OpenAlexW2617830924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.